Can PRP Injection Cause Lymph Node Swelling and Flu-Like Symptoms?
Yes, PRP injections can cause lymph node swelling and flu-like symptoms, though these reactions are uncommon adverse events that have been documented in the medical literature.
Documented Cases of Lymphadenopathy
A case report specifically documented acute, painful cervical lymphadenopathy occurring shortly after PRP treatment combined with microneedling therapy 1. This represents direct evidence that lymph node swelling can occur as a complication of PRP procedures. The authors emphasized that this potential adverse effect should be included in patient consent forms and doctor-patient education 1.
Inflammatory and Systemic Reactions
Exuberant Inflammatory Response
PRP can trigger significant inflammatory reactions beyond the injection site. One documented case showed an exuberant inflammatory reaction after PRP injection for tendinopathy, particularly in a patient with insulin-dependent diabetes 2. This suggests that systemic inflammatory responses are possible, which could manifest as flu-like symptoms.
Systemic Growth Factor Effects
Research has demonstrated that PRP injections cause systemic elevation of growth factors including:
- IGF-1 (elevated at 24 and 48 hours post-injection)
- VEGF (elevated at 3,24,48,72, and 96 hours - present in 100% of patients)
- bFGF (elevated at 72 and 96 hours)
These systemic changes indicate that PRP triggers biological pathways throughout the body, not just locally 3. Such systemic activation could reasonably produce flu-like symptoms as the body responds to these circulating factors.
Allergic and Hypersensitivity Reactions
Allergic reactions to PRP components have been documented, despite the autologous nature of the treatment 4. One case report described a patient who developed:
- Skin rash within 24 hours
- Pharyngitis and tonsillar enlargement
- Mucopurulent discharge
- Eyelid swelling
The reaction was attributed to calcium citrate used in PRP preparation 4. This demonstrates that additives and processing agents can trigger immune responses that may include lymphadenopathy and systemic symptoms.
Clinical Context and Safety Profile
General Safety Considerations
While PRP is generally considered safe due to its autologous nature 5, the literature acknowledges that "safety of use of PRP is not absolutely sure" 4. The preparation process and additives can substantially decrease safety despite using the patient's own tissue.
Leukocyte Content Impact
The presence of leukocytes in PRP preparations (L-PRP) may significantly impact biological responses, as leukocytes are "key players in tissue healing and local growth factor regulation" 5. Leukocyte-rich preparations could theoretically trigger more pronounced immune responses, including lymph node activation.
Clinical Recommendations
When evaluating a patient with lymph node swelling and flu-like symptoms after PRP:
Timing is critical: Symptoms typically appear within 24-96 hours post-injection based on documented cases 1, 4
Assess for infection vs. inflammatory response: Rule out bacterial infection while recognizing that sterile inflammatory reactions are possible
Consider preparation components: Inquire about specific PRP preparation method and additives (calcium citrate, anticoagulants) that may trigger reactions 4
Monitor systemically: Check for skin manifestations, pharyngeal symptoms, and other signs of systemic reaction beyond just lymphadenopathy 4
Treatment approach: Antihistamines (loratadine, clemastine) have been successfully used for allergic-type reactions 4, though most inflammatory responses are self-limited
Important Caveats
Documentation is limited: These adverse events are rarely reported in the literature, suggesting they are uncommon but likely underreported 1
Patient-specific factors matter: Patients with diabetes or other comorbidities may be at higher risk for exaggerated inflammatory responses 2
Preparation variability: The heterogeneity in PRP preparation methods means that different products may carry different risk profiles 5
The bottom line: While PRP is marketed as safe and minimally invasive, clinicians must recognize that lymphadenopathy and systemic symptoms can occur and should counsel patients accordingly before treatment.